U.S. drugmakers Johnson & Johnson and Eli Lilly increased spending on security for their top executives in 2024, with both ...

After scoring a long-awaited FDA approval last fall, Eli Lilly has launched a consumer-facing campaign to get the word out ...

Highlights,Institutional investors have adjusted their holdings in Eli Lilly and Company, with several firms increasing ...

Novo Nordisk released the results from its late-stage trial of CagriSema on Monday. It showed that patients on the highest dose of the drug lost 15.7% of their weight.

Talk about a star-packed Oscar Week. The days and nights leading up to Hollywood’s biggest event of the year began this time ...

Network highlights graduates shaping the fields of law, banking, finance, education, health care, media, science, technology ...

House Bill 1879 passed unanimously March 4 on a 95-0 vote, according to the chamber's website. State senators will now ...

Eli Lilly (NYSE: LLY) stock has had plenty of good trading sessions over the past year or so, but Monday's sure wasn't among ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...